[Thiacetazone (Tb-1): recent experimental and clinical data].
D000636:Aminosalicylic Acids / Q000494:pharmacology; D000818:Animals; D003523:Cycloserine / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000494:pharmacology; D005843:Geography; D006168:Guinea Pigs; D006413:Hematopoietic System / Q000187:drug effects; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D051379:Mice; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D012877:Skin Manifestations; D013307:Streptomycin / Q000627:therapeutic use; D013828:Thioacetazone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D003523:Cycloserine; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
La thiacétazone (Tb-1): données expérimentales et cliniques récentes.